『Inhaled KB707 Plus Pembrolizumab in Lung Cancer』のカバーアート

Inhaled KB707 Plus Pembrolizumab in Lung Cancer

Inhaled KB707 Plus Pembrolizumab in Lung Cancer

無料で聴く

ポッドキャストの詳細を見る

プレミアムプランが3か月 月額99円

登録で500円分のAmazonギフトカードプレゼント。12月23日まで。※適用条件あり
概要

Patients with advanced lung cancer often experience disease progression despite treatment with immune checkpoint inhibitors. In this episode of Cancer Advances, Wen Wee Ma, MBBS, discusses data evaluating inhaled KB707, a modified herpes simplex virus designed to locally deliver IL-2 and IL-12, in combination with pembrolizumab. Dr. Ma reviews the rationale behind this novel immunotherapy approach, early efficacy and safety findings and the potential role of inhaled therapies in future lung cancer treatment strategies.

adbl_web_anon_alc_button_suppression_t1
まだレビューはありません